Atlas Trials

Diffuse Large B-cell Lymphoma With no Other Specification

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Diffuse Large B-cell Lymphoma With no Other Specification

RecordFirmDate
A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (NCT07044050)Emercell SAS2025-06-10

Track Diffuse Large B-cell Lymphoma With no Other Specification automatically

Every clearance here is in the API, with alerts when new ones post.